Showing results (411-420 of 450) with videos related to
Sort By:
Pageof 45
Cancer|December 15, 1988
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyG N Hortobagyi, F C Ames, A U Buzdar, et al.Cell Reports. Medicine|April 21, 2026
Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDSLéo Marx, Josée Hue-Perron, Alain Monjardet, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2018
Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MSDeborah N Schoonhoven, Matteo Fraschini, Prejaas Tewarie, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancerF A Holmes, V Valero, R S Walters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancerV Valero, F A Holmes, R S Walters, et al.Journal of Medicinal Chemistry|August 25, 2001
2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonistsG Spadoni, C Balsamini, G Diamantini, et al.Journal of Medicinal Chemistry|September 28, 1998
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) studyM Mor, S Rivara, C Silva, et al.European Heart Journal. Imaging Methods and Practice|March 5, 2025
Impact of loading, heart rate, and short episodes of ischaemia on myocardial stiffness assessed using shear wave elastography in an open-chest animal modelEric Saloux, Christophe Simard, Pauline Ruello, et al.Cancer|January 15, 1992
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapyA U Buzdar, S W Kau, G N Hortobagyi, et al.Bioorganic & Medicinal Chemistry|May 17, 2001
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligandsM Mor, G Spadoni, B Di Giacomo, et al.Pageof 45